A sell-side mandate in connection with the potential divestment of a mid-cap Turkey-based operation of a listed European pharmaceutical player, as the site no longer fits in the Group’s portfolio of assets post change in group strategy.
Key sticking/ pain points:
Delays or inconsistencies in responses due to management being focused on day-to-day operations, not prepared for the intensity of diligence.
Data retrieval was delayed due to the need to gather information from multiple, uncoordinated sources.
The onsite team was unfamiliar with the requirements of such a transaction, which resulted in timeline slippages.
Hillpine’s value proposition
Data preparation & structuring
Build a detailed pro forma revenue and margin model at the SKU level, reflecting the revised commercial terms and aligned to the go-forward operating structure, with multiple supporting data fields.
The data structure was complex, with varying levels of detail that were not fully aligned or consistently categorized, leading to additional reconciliation efforts.
Deliverables
Structured transactional database;
Historical trading performance;
Performed revenue and margin analysis segmented by revenue stream, product family, geography, and customer.
Provided ongoing support in drafting and refining the Information Memorandum.
Delivered tailored financial analyses aligned with the expected requirements of potential bidders.
Overall management of the transaction/project
Organization of relevant/ pertinent documents in the VDR;
Providing additional information and responding to prospective bidders;
Leading and managing the Q&A process and expert sessions.
